USD10
RCKT Shares
About Rocket PharmaceuticalsRocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
USD10
RCKT Shares
About Rocket PharmaceuticalsRocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$369.1M
OPEN PRICE
$3.34
LOW (1Y)
$2.53
HIGH (1Y)
$5.45
LOW (24H)
$3.26
HIGH (24H)
$3.45
VOLUME (24H)
$1.48M
4.98%
Price history
Time | Price | Change |
|---|---|---|
Today | $3.34 | |
1 Day | $3.42 | |
1 Week | $3.85 | |
1 Month | $3.24 | |
1 Year | $3.13 |
Past performance is not a reliable indicator of future results.
Discover more
Learn how to buy popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.